Digital Therapeutics Market

Table Of Contents

1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1 Chapter Overview
3.2. Digitization in the Healthcare Sector
3.3. Next-Generation Healthcare Solutions

3.4. Key Concepts Associated with Digital Health Solutions
3.4.1. Cognitive Behavioral Therapy (CBT)
3.4.2. Internet of Things (IoT)
3.4.3. Big Data
3.4.4. Artificial Intelligence (AI)
3.4.5. Gamification

3.5. Overview of Digital Therapeutics
3.5.1. Key Strategic Initiatives
3.5.1.1. Digital Therapeutics Alliance (DTA)
3.5.1.2. Personal Connected Health (PCH) Alliance
3.5.1.3. Programs Initiated by The Centers for Disease Control and Prevention (CDC)
3.5.1.4. Health Insurance Portability and Accountability Act (HIPAA)
3.5.1.5. National Health Service (NHS) Guidelines
3.5.1.6. United States Food and Drug Administration (USFDA) Regulations for Digital Therapeutics

3.5.2. Typical Development and Commercialization Path for Digital Therapeutics
3.5.2.1. Discovery and Preclinical Phase
3.5.2.2. Clinical Trials and Validation
3.5.2.3. Negotiation Involving Insurance Providers / Payers
3.5.2.4. Distribution and Marketing

3.6 Concluding Remarks

4. CURRENT MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Digital Therapeutics: Overall Market Landscape
4.2.1. Analysis by Status of Development
4.2.2. Analysis by Type of Solution
4.2.3. Analysis by Type of Therapy
4.2.4. Analysis by Purpose of Solution
4.2.5. Analysis by Target Indication
4.2.6. Analysis by Therapeutic Area
4.2.7. Analysis by Target Population

4.3. Digital Therapeutics: Additional Information
4.3.1. Analysis by Requirement of Prescription
4.3.2. Analysis by Duration of Course
4.3.3. Analysis by Cost of Solution

4.4. Digital Therapeutics: List of Developers
4.4.1. Analysis by Year of Establishment
4.4.2. Analysis by Company Size
4.4.3. Analysis by Type of Business Model
4.4.4 Analysis by Location of Headquarters

4.5. Leading Developers: Analysis by Number of Digital Therapeutic Solutions
4.6. Leading Developers: Analysis by Portfolio Strength, Target Indication, and Company Size (4D Bubble Representation)
4.7. Analysis by Therapeutic Area and Company Size (Tree Map Representation)
4.8. Analysis of Regional Activity (World Map Representation)

5. PRODUCT COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions / Key Parameter
5.3. Methodology
5.4. Key Therapeutic Areas
5.4.1. Product Competitive Analysis: Digital Therapeutics Targeting Cardiovascular Disorders
5.4.2. Product Competitive Analysis: Digital Therapeutics Targeting Mental Health Problems
5.4.3. Product Competitive Analysis: Digital Therapeutics Targeting Metabolic Disorders
5.4.4. Product Competitive Analysis: Digital Therapeutics Targeting Neurological Disorders
5.4.5. Product Competitive Analysis: Digital Therapeutics Targeting Substance Use Disorders
5.4.6. Product Competitive Analysis: Digital Therapeutics Targeting Other Therapeutic Areas

6. COMPANY PROFILES
6.1. Chapter Overview
6.2. Akili Interactive
6.2.1 Company Overview
6.2.2. Product Portfolio
6.2.3. Recent Developments and Future Outlook

6.3. Big Health
6.3.1. Company Overview
6.3.2. Product Portfolio
6.3.3. Recent Developments and Future Outlook

6.4. dreem
6.4.1. Company Overview
6.4.2. Product Portfolio
6.4.3. Recent Developments and Future Outlook

6.5 Kaia Health
6.5.1. Company Overview
6.5.2. Product Portfolio
6.5.3. Recent Developments and Future Outlook

6.6. MindMaze
6.6.1. Company Overview
6.6.2. Product Portfolio
6.6.3. Recent Developments and Future Outlook

6.7. Omada Health
6.7.1. Company Overview
6.7.2. Product Portfolio
6.7.3. Recent Developments and Future Outlook

6.8. Pear Therapeutics
6.8.1. Company Overview
6.8.2. Product Portfolio
6.8.3 Recent Developments and Future Outlook

6.9. Vida Health
6.9.1. Company Overview
6.9.2. Product Portfolio
6.9.3. Recent Developments and Future Outlook

6.10. Voluntis
6.10.1. Company Overview
6.10.2. Product Portfolio
6.10.3. Recent Developments and Future Outlook

6.11. WellDoc
6.11.1. Company Overview
6.11.2. Product Portfolio
6.11.3. Recent Developments and Future Outlook

6.12. Wellthy Therapeutics
6.12.1. Company Overview
6.12.2. Product Portfolio
6.12.3. Recent Developments and Future Outlook

7. CLINICAL TRIAL ANALYSIS
7.1. Chapter Overview
7.2. Scope and Methodology

7.3. Digital Therapeutics: Clinical Trial Analysis
7.3.1. Analysis by Trial Registration Year
7.3.2. Analysis by Trial Status
7.3.3. Analysis by Trial Registration Year and Trial Status
7.3.4. Analysis by Trial Phase
7.3.5. Analysis by Type of Study
7.3.6. Analysis by Study Design
7.3.7. Analysis by Study Age
7.3.8. Analysis by Gender of Patients
7.3.9. Analysis of Patients Enrolled by Trial Registration Year
7.3.10. Analysis by Type of Sponsor
7.3.11. Analysis by Focus Area
7.3.12. Analysis by Geography
7.3.13. Analysis by Trial Registration Year, Recruitment Status and Geography
7.3.14. Analysis of Patients Enrolled by Geography

7.4. Clinical End-Points Analysis

8. FUNDING AND INVESTMENT ANALYSIS
8.1. Chapter Overview
8.2. Type of Funding Models

8.3. Digital therapeutics: List of Funding and Investments
8.3.1 Analysis of Number of Funding Instances by Year of Establishment and Type of Funding
8.3.2. Analysis of Funding Instances by Year
8.3.3. Analysis of Amount Invested by Year
8.3.4. Analysis by Type of Funding
8.3.5. Analysis of Instances and Amount Invested by Type of Therapy
8.3.6. Analysis by Therapeutic Area
8.3.7. Analysis by Geography
8.3.8. Most Active Players: Analysis by Number of Instances
8.3.9. Most Active Players: Analysis by Amount Raised
8.3.10. Most Active Investors: Analysis by Number of Instances

8.4. Concluding Remarks

9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Digital Therapeutics: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership

9.3.2. Analysis by Type of Partnership
9.3.2.1. Analysis by Year of Partnership and Type of Partnership
9.3.2.2. Analysis by Type of Partnership and Company Size

9.3.3. Analysis by Type of Partner
9.3.3.1. Analysis by Year of Partnership and Type of Partner
9.3.3.2. Analysis by Type of Partnership and Type of Partner
9.3.3.3 Analysis by Type of Partner and Company Size

9.3.4. Analysis by Type of Therapy
9.3.4.1. Analysis by Type of Partnership and Type of Therapy
9.3.4.2. Analysis by Type of Partner and Type of Therapy

9.3.5. Analysis by Therapeutic Area
9.3.5.1. Analysis by Year of Partnership and Therapeutic Area
9.3.5.2 Analysis by Type of Partner and Therapeutic Area

9.3.6. Most Active Players: Analysis by Number of Partnerships
9.3.7. Analysis by Geography
9.3.8. Intercontinental and Intracontinental Agreements

10. GO-TO-MARKET STRATEGY
10.1. Chapter Overview
10.2. Marketing Strategies Adopted by Digital Therapeutic Developers
10.2.1. Participation in Global Events
10.2.2. Marketing on Social Media Platforms
10.2.3. Marketing on Online / Print Media Platforms
10.2.4. Undertaking Various Promotional Activities through Official Websites
10.2.5. Adoption of Different Business Models
10.2.5.1. B2C Business Model
10.2.5.2. B2B Business Model
10.2.5.2. B2B2C Business Model

10.2.6. Undertaking Various Promotional Activities through Product Add-ons
10.3. Concluding Remarks

11. BOWMAN CLOCK PRICING STRATEGY ANALYSIS
11.1. Chapter Overview
11.2. Bowman Strategy Clock
11.2.1. Two Dimensions of Bowman Strategy Clock
11.2.2. Eight Positions on Bowman Strategic Clock

11.3 Roots Analysis Framework
11.3.1. Methodology
11.3.2. Theoretical Framework and Price Evaluation Hypothesis
11.3.3. Results and Interpretation
11.3.3.1. Product Price Evaluation Matrix: Based on Status of Development
11.3.3.2. Product Price Evaluation Matrix: Based on Type of Solution
11.3.3.3. Product Price Evaluation Matrix: Based on Purpose of Solution
11.3.3.4. Product Price Evaluation Matrix: Based on Type of Therapy
11.3.3.5. Product Price Evaluation Matrix: Based on Therapeutic Area
11.3.3.6. Product Price Evaluation Matrix: Based on Prescription Requirement
11.3.3.7. Product Price Evaluation Matrix: Based on Duration of Course
11.3.3.8. Product Price Evaluation Matrix: Based on Distribution Channel
11.4. Concluding Remarks

12. MARKET FORECAST
12.1. Chapter Overview
12.2. Forecast Methodology and Key Assumptions
12.3. Global Digital Therapeutics Market, 2022-2035

12.4. Digital Therapeutics Market: Analysis by Type of Solution, 2022-2035
12.4.1. Digital Therapeutics Market for Standalone Software Applications, 2022-2035
12.4.2. Digital Therapeutics Market for Combination Offerings focused on Software Application, Device and Personal Coach, 2022-2035
12.4.3. Digital Therapeutics Market for Combination Offerings focused on Software Application and Personal Coach, 2022-2035
12.4.4. Digital Therapeutics Market for Combination Offerings focused on Software Application and AI Support, 2022-2035
12.4.5. Digital Therapeutics Market for Combination Offerings focused on Software Application and Device), 2022-2035
12.4.6. Digital Therapeutics Market for Combination Offerings focused on Software Application, Device and AI Support), 2022-2035
12.4.7. Digital Therapeutics Market for Other Types of Solutions, 2022-2035

12.5. Digital Therapeutics Market: Analysis by Purpose of Solution, 2022-2035
12.5.1. Digital Therapeutics Market for Medication Replacement Solutions, 2022-2035
12.5.2. Digital Therapeutics Market for Medication Augmentation Solutions, 2022-2035

12.6. Digital Therapeutics Market: Analysis by Type of Therapy, 2022-2035
12.6.1 Digital Therapeutics Market for Curative Therapy, 2022-2035
12.6.2. Digital Therapeutics Market for Preventive Therapy, 2022-2035

12.7. Digital Therapeutics Market: Analysis by Business Model, 2022-2035
12.7.1. Digital Therapeutics Market for B2C Model, 2022-2035
12.7.2. Digital Therapeutics Market for B2B Model, 2022-2035

12.8. Digital Therapeutics Market: Analysis by Therapeutic Area, 2022-2035
12.8.1. Digital Therapeutics Market for Cardiovascular Disorders, 2022-2035
12.8.2. Digital Therapeutics Market for Chronic Pain, 2022-2035
12.8.3. Digital Therapeutics Market for Mental Health Problems, 2022-2035
12.8.4. Digital Therapeutics Market for Metabolic Disorders, 2022-2035
12.8.5. Digital Therapeutics Market for Neurological Disorders, 2022-2035
12.8.6. Digital Therapeutics Market for Respiratory Disorders, 2022-2035
12.8.7. Digital Therapeutics Market for Sleep Disorders, 2022-2035
12.8.8. Digital Therapeutics Market for Substance Use Disorders, 2022-2035
12.8.9. Digital Therapeutics Market for Other Disorders, 2022-2035

12.9. Digital Therapeutics Market: Analysis by Geography, 2022-2035
12.9.1. Digital Therapeutics Market in North America, 2022-2035
12.9.2. Digital Therapeutics Market in Europe, 2022-2035
12.9.3. Digital Therapeutics Market in Asia, 2022-2035
12.9.4. Digital Therapeutics Market in MENA, 2022-2035
12.9.5. Digital Therapeutics Market in Latin America, 2022-2035
12.9.6. Digital Therapeutics Market in Rest of the World, 2022-2035

12.10. Concluding Remarks

13. WOMEN DIGITAL HEALTH: AN EMERGING NEW CONCEPT
13.1. Introduction: Women Digital Health
13.2. Chapter Overview
13.3. Women’s Digital Health: Product Pipeline
13.3.1. Analysis by Type of Solution
13.3.2. Analysis by Status of Development
13.3.3. Analysis by Product Ratings
13.3.4. Analysis by Application Area
13.3.5. Analysis of Products by Different Stages of Pregnancy
13.3.6. Analysis by Purpose of Solution
13.3.7. Analysis by Type of End-Users
13.3.8. Analysis by Type of Solution and Application Area

13.4. Women’s Digital Health: Developer's Landscape
13.4.1. Analysis by Year of Establishment
13.4.2. Analysis by Company Size
13.4.3. Analysis by Location of Headquarters (Region-wise)
13.4.4. Analysis by Company Size and Region
13.4.5. Analysis by Location of Headquarters (Country-Wise)
13.4.6. Leading Players: Analysis by Number of Solutions
13.4.7. Regional Landscape: Analysis by Type of Solution

14. SWOT ANALYSIS
14.1. Chapter Overview
14.2. Comparison of SWOT Factors
14.2.1. Strengths
14.2.2. Weaknesses
14.2.3. Opportunities
14.2.4. Threats
14.2.5. Conclusion

15. EXECUTIVE INSIGHTS
15.1. Chapter Overview
15.2. Ampersand Health
15.2.1. Company Snapshot
15.2.2. Interview Transcript: Radhika Kamalia, Chief of Staffs to CEO and Strategy Lead

15.3. Canary Health
15.3.1. Company Snapshot
15.3.2. Interview Transcript: Adam Kaufman, Ex-Chief Executive Officer

15.4. Dnurse Technology
15.4.1. Company Snapshot
15.4.2. Interview Transcript: Cindy Zhang, Marketing Director

15.5. Embr Labs
15.5.1. Company Snapshot
15.5.2. Interview Transcript: Healther Ritchie, Chief Strategy Officer

15.6. Exosystems
15.6.1. Company Snapshot
15.6.2. Interview Transcript: Hooman Lee, Founder and Chief Executive Officer

15.7. Floreo
15.7.1. Company Snapshot
15.7.2. Interview Transcript: Vijay Ravindran, Chief Executive Officer

15.8. GAIA
15.8.1. Company Snapshot
15.8.2. Interview Transcript: Stan Sugarman, Chief Commercial Officer

15.9. Healios
15.9.1. Company Snapshot
15.9.2. Interview Transcript: Guilhem Dupnot , Founder and Chief Executive Officer

15.1 JOGGO Health
15.10.1. Company Snapshot
15.10.2. Interview Transcript: Siva Nadarajah, Co-Founder and President

15.11. metaMe Health
15.11.1. Company Snapshot
15.11.2 Interview Transcript: Tim Rudolphi, Chief Executive Officer

15.12. SelfBack
15.12.1. Company Snapshot
15.12.2. Interview Transcript: Soren Kleberg, Chief Executive Officer

15.13. Somatix
15.13.1. Company Snapshot
15.13.2. Interview Transcript: Eran Ofir, Ex-Chief Executive Officer

15.14. Tilak Healthcare
15.14.1. Company Snapshot
15.14.2. Interview Transcript: Edouard Gasser, Chief Executive Officer

15.15. Turnaround Health
15.15.1. Company Snapshot
15.15.2. Interview Transcript: Torin Block, Chief Executive Officer

15.16. Vida Health
15.16.1. Company Snapshot
15.16.2. Interview Transcript: Stephanie Tilenius, Co-Founder and Chief Executive Officer

15.17. Voluntis
15.17.1. Company Snapshot
15.17.2. Interview Transcript: Amelie Janson, Ex-Communication Manager

15.18. Wellthy Therapeutics
15.18.1. Company Snapshot
15.18.2. Interview Transcript: Palakh R Sarogi, Ex-Vice President Marketing, Arani Sarkra Ex-Senior Manager Consumer Marketing, and Yolande D’Mello, Ex-Marketing and Public Relations

15.19. Undisclosed
15.19.1. Interview Transcript: Anonymous, Founder and Chief Executive Officer

16. CONCLUDING REMARKS

17. APPENDIX 1: TABULATED DATA

18. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 3.1 Digital Health: Major Causes for Chronic Diseases
Figure 3.2 Historical Timeline of Digital Health: Analysis of Google Trends
Figure 3.3 Internet of Things: General Framework
Figure 3.4 Internet of Things: Applications in the Healthcare Sector
Figure 3.5 Prescription Digital Therapeutics: Process Map
Figure 3.6 Characteristics of a Digital Therapeutic Program: An Illustration
Figure 4.1 Digital Therapeutics: Distribution by Status of Development
Figure 4.2 Digital Therapeutics: Distribution by Type of Solution
Figure 4.3 Digital Therapeutics: Distribution by Type of Therapy
Figure 4.4 Digital Therapeutics: Distribution by Purpose of Solution
Figure 4.5 Digital Therapeutics: Distribution by Type of Therapy and Purpose of Solution
Figure 4.6 Digital Therapeutics: Distribution by Target Indication
Figure 4.7 Digital Therapeutics: Distribution by Therapeutic Area
Figure 4.8 Digital Therapeutics: Distribution by Target Population
Figure 4.9 Digital Therapeutic Solutions: Distribution by Prescription Requirements
Figure 4.10 Digital Therapeutic Solutions: Distribution by Duration of Course
Figure 4.11 Digital Therapeutic Solutions: Distribution by Cost of Solutions (USD)
Figure 4.12 Digital Therapeutic Developers: Distribution by Year of Establishment
Figure 4.13 Digital Therapeutics Developers: Distribution by Company Size
Figure 4.14 Digital Therapeutics Developers: Distribution by Business Model
Figure 4.15 Digital Therapeutics Developers: Distribution by Location of Headquarters
Figure 4.16 Leading Digital Therapeutics Developers: Distribution by Number of Digital Therapeutic Solutions
Figure 4.17 Leading Digital Therapeutics Developers: Distribution by Portfolio Strength, Therapeutic Area and Company Size (4-D Bubble Representation)
Figure 4.18 Digital Therapeutics: Distribution by Therapeutic Area and Company Size (Tree Map Representation)
Figure 4.19 Digital Therapeutics: Distribution of Regional Activity (World Map Representation)
Figure 5.1 Cardiovascular Disorders: Shift in Trends (2018-2023)
Figure 5.2 Product Competitiveness Analysis: Cardiovascular Disorders
Figure 5.3 Mental Health Problems: Shift in Trends (2018-2023)
Figure 5.4 Product Competitiveness Analysis: Mental Health Problems
Figure 5.5 Metabolic Disorders: Shift in Trends (2018-2023)
Figure 5.6 Product Competitiveness Analysis: Metabolic Disorders
Figure 5.7 Neurological Disorders: Shift in Trends (2018-2023)
Figure 5.8 Product Competitiveness Analysis: Neurological Disorders
Figure 5.9 Substance Use Disorders: Shift in Trends (2018-2023)
Figure 5.10 Product Competitiveness Analysis: Substance Use Disorders
Figure 5.11 Other Therapeutic Areas: Shift in Trends (2018-2023)
Figure 5.12 Product Competitiveness Analysis: Other Therapeutic Areas
Figure 6.1 Akili Interactive: Core Technologies and Benefits of Digital Products
Figure 6.2 Big Health: Digital Therapeutics Products and Clinical Trial Outcomes
Figure 6.3 WellDoc: Key Benefits of Diabetes Management Program
Figure 6.4 Wellthy Therapeutics: Diabetes Program
Figure 7.1 Key Methods to Validate Digital Therapeutic Solutions
Figure 7.2 Clinical Trial Analysis: Scope and Methodology
Figure 7.3 Clinical Trial Analysis: Cumulative Year-wise Trend of Trials by Trial Registration Year, Pre-2017-2022
Figure 7.4 Clinical Trial Analysis: Distribution by Trial Status
Figure 7.5 Clinical Trial Analysis: Distribution by Trial Registration Year and Trial Status
Figure 7.6 Clinical Trial Analysis: Distribution by Trial Phase
Figure 7.7 Clinical Trial Analysis: Distribution by Type of Study
Figure 7.8 Clinical Trial Analysis: Distribution by Study Design
Figure 7.9 Clinical Trial Analysis: Distribution by Study Age
Figure 7.10 Clinical Trial Analysis: Distribution by Gender of Patients
Figure 7.11 Clinical Trial Analysis: Distribution of Patient Enrolled by Trial Registration Year
Figure 7.12 Clinical Trial Analysis: Distribution by Type of Sponsor
Figure 7.13 Clinical Trial Analysis: Distribution by Focus Area
Figure 7.14 Clinical Trial Analysis: Distribution of Trials by Geography
Figure 7.15 Clinical Trial Analysis: Distribution by Trial Registration Year, Recruitment Status and Geography
Figure 7.16 Clinical Trial Analysis: Distribution of Patients Enrolled by Geography
Figure 7.17 Clinical End-Points Analysis
Figure 7.18 Clinical Trials Analysis: Key Clinical End-Points for Metabolic Disorders
Figure 7.19 Clinical Trial Analysis: Primary and Secondary Clinical End-Points for Metabolic Disorders
Figure 8.1 Funding and Investment Analysis: Distribution of Instances by Year of Establishment and Type of Funding
Figure 8.2 Funding and Investment Analysis: Cumulative Year-wise Distribution of Instances, Pre-2019 - 2022
Figure 8.3 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, Pre-2019 - 2022 (USD Million)
Figure 8.4 Funding and Investment Analysis: Distribution of Instances by Type of Funding
Figure 8.5 Funding and Investment Analysis: Distribution of Instances by Year and Type of Funding, 2016 - 2022
Figure 8.6 Funding and Investment Analysis: Distribution of Amount Invested by Year and Type of Funding, 2016- 2022 (USD Million)
Figure 8.7 Funding and Investment Analysis: Summary of Amount Invested, 2016-2022
Figure 8.9 Funding and Investment Analysis: Distribution of Instances and Amount Invested by Type of Therapy (USD Million)
Figure 8.10 Funding and Investment Analysis: Distribution of Instances by Year and Type of Therapy, 2016 - 2022
Figure 8.11 Funding and Investment Analysis: Distribution of Amount Invested by Year and Type of Therapy, Pre-2019 - 2022 (USD Million)
Figure 8.12 Funding and Investment Analysis: Distribution of Instances by Therapeutic Area
Figure 8.13 Funding and Investment Analysis: Distribution of Amount Invested by Therapeutic Area (USD Million)
Figure 8.14 Funding and Investment Analysis: Distribution of Instances by Geography
Figure 8.15 Funding and Investment Analysis: Distribution of Amount Invested by Geography (USD Million)
Figure 8.16 Most Active Players: Distribution by Number of Instances
Figure 8.17 Most Active Players: Distribution by Amount Raised (USD Million)
Figure 8.18 Most Active Investors: Distribution by Number of Instances
Figure 8.19 Funding and Investment Summary, Pre-2019-2022 (USD Million)
Figure 9.1 Partnerships and Collaborations: Cumulative Year-Wise Trend, Pre-2016 - 2022
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Year-Wise Trend by Type of Partnership, Pre-2016 - 2022
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Figure 9.5 Partnerships and Collaborations: Distribution by Type of Partner
Figure 9.6 Partnerships and Collaborations: Year-Wise Trend by Type of Partner, Pre-2016 - 2022
Figure 9.7 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Figure 9.8 Partnerships and Collaborations: Distribution by Type of Partner and Company Size
Figure 9.9 Partnerships and Collaborations: Distribution by Type of Therapy
Figure 9.10 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Therapy
Figure 9.11 Partnerships and Collaborations: Distribution by Type of Partner and Type of Therapy
Figure 9.12 Partnerships and Collaborations: Distribution by Therapeutic Area
Figure 9.13 Partnerships and Collaborations: Year-Wise Trend by Therapeutic Area
Figure 9.14 Partnerships and Collaborations: Distribution by Type of Partner and Therapeutic Area
Figure 9.15 Most Active Players: Distribution by Number of Partnerships
Figure 9.16 Partnerships and Collaborations: Regional Distribution
Figure 9.17 Partnerships and Collaborations: Country-Wise Distribution
Figure 9.18 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 10.1 Go-to-Market Strategy: Commonly Used Social Media Platforms
Figure 10.2 Go-to-Market Strategy: Online / Print Media Platforms
Figure 10.3 Go-to-Market Strategy: Promotional Activities through Official Websites
Figure 10.4 Go-to-Market Strategy: Adoption of Different Business Model
Figure 10.5 Go-to-Market Strategy: Promotional Activities through Product Websites
Figure 10.6 Go-to-Market Strategy: Key Marketing Strategies for New Entrants
Figure 10.7 Go-to-Market Strategy: Industry Stakeholder Opinions
Figure 11.1 Digital Therapeutics: Bowman Clock Pricing Strategy Matrix
Figure 11.2 Digital Therapeutics: Bowman Clock Pricing Strategy Graphical Interpretation
Figure 12.1 Overall Digital Therapeutics Market, 2022-2035 (USD Million)
Figure 12.2 Digital Therapeutics Market: Distribution by Type of Solution, 2022-2035 (USD Million)
Figure 12.3 Digital Therapeutics Market for Standalone Software Applications 2022-2035 (USD Million)
Figure 12.4 Digital Therapeutics Market for Combination Offerings of Software Application, Device and Personal Coach, 2022-2035 (USD Million)
Figure 12.5 Digital Therapeutics Market for Combination Offerings of Software Application and Personal Coach, 2022-2035 (USD Million)
Figure 12.6 Digital Therapeutics Market for Combination Offerings of Software Application and AI Support, 2022-2035 (USD Million)
Figure 12.7 Digital Therapeutics Market for Combination Offerings of Software Application and Device, 2022-2035 (USD Million)
Figure 12.8 Digital Therapeutics Market for Combination Offerings of Software Application, Device and AI Support, 2022-2035 (USD Million)
Figure 12.9 Digital Therapeutics Market for Other Types of Solutions, 2022-2035 (USD Million)
Figure 12.10 Digital Therapeutics Market: Distribution by Purpose of Solution, 2022-2035
Figure 12.11 Digital Therapeutics Market for Medication Replacement Solutions, 2022-2035 (USD Million)
Figure 12.12 Digital Therapeutics Market for Medication Augmentation Solutions, 2022-2035 (USD Million)
Figure 12.13 Digital Therapeutics Market: Distribution by Type of Therapy, 2022-2035 (USD Million)
Figure 12.14 Digital Therapeutics Market for Curative Therapies, 2022-2035 (USD Million)
Figure 12.15 Digital Therapeutics Market for Preventive Therapies, 2022-2035 (USD Million)
Figure 12.16 Digital Therapeutics Market: Distribution by Business Model, 2022-2035 (USD Million)
Figure 12.17 Digital Therapeutics Market for B2C Model, 2022-2035 (USD Million)
Figure 12.18 Digital Therapeutics Market for B2B Model, 2022-2035 (USD Million)
Figure 12.19 Digital Therapeutics Market: Distribution by Therapeutic Area, 2022-2035 (USD Million)
Figure 12.20 Digital Therapeutics Market for Cardiovascular Disorders, 2022-2035 (USD Million)
Figure 12.21 Digital Therapeutics Market for Chronic Pain, 2022-2035 (USD Million)
Figure 12.22 Digital Therapeutics Market for Mental Health Problems, 2022-2035 (USD Million)
Figure 12.23 Digital Therapeutics Market for Metabolic Disorders, 2022-2035 (USD Million)
Figure 12.24 Digital Therapeutics Market for Neurological Disorders, 2022-2035 (USD Million)
Figure 12.25 Digital Therapeutics Market for Respiratory Disorders, 2022-2035 (USD Million)
Figure 12.26 Digital Therapeutics Market for Sleep Disorders 2022-2035 (USD Million)
Figure 12.27 Digital Therapeutics Market for Substance Use Disorders, 2022-2035 (USD Million)
Figure 12.28 Digital Therapeutics Market for Other Disorders, 2022-2035 (USD Million)
Figure 12.29 Digital Therapeutics Market: Distribution by Geography, 2022-2035 (USD Million)
Figure 12.30 Digital Therapeutics Market in North America, 2022-2035 (USD Million)
Figure 12.31 Digital Therapeutics Market in Europe, 2022-2035 (USD Million)
Figure 12.32 Digital Therapeutics Market in Asia, 2022-2035 (USD Million)
Figure 12.33 Digital Therapeutics Market in MENA, 2022-2035 (USD Million
Figure 12.34 Digital Therapeutics Market in Latin America, 2022-2035 (USD Million
Figure 12.35 Digital Therapeutics Market in Rest of the World, 2022-2035 (USD Million)
Figure 13.1 Women’s Digital Health: Distribution by Type of Solution
Figure 13.2 Women’s Digital Health: Distribution by Status of Development
Figure 13.3 Women’s Digital Health: Distribution by Product Ratings
Figure 13.4 Women’s Digital Health: Distribution by Application Area
Figure 13.5 Women’s Digital Health: Distribution of Products used during Stages of Pregnancy
Figure 13.6 Women’s Digital Health: Distribution by Purpose of Solution
Figure 13.7 Women’s Digital Health: Distribution by Type of End-Users
Figure 13.8 Women’s Digital Health: Distribution by Type of Solution and Application Area
Figure 13.9 Women’s Digital Health Developers: Distribution by Year of Establishment
Figure 13.10 Women’s Digital Health Developers: Distribution by Company Size
Figure 13.11 Women’s Digital Health Developers: Distribution by Location of Headquarters (Region-wise)
Figure 13.12 Women’s Digital Health Developers: Distribution by Company Size and Region
Figure 13.13 Women’s Digital Health Developers: Distribution by Location of Headquarters (Country-wise)
Figure 13.14 Leading Players: Distribution by Number of Solutions
Figure 13.15 Regional Landscape: Distribution by Type of Solution
Figure 14.1 Digital Therapeutics: Overview of SWOT Analysis
Figure 14.2 Comparison of SWOT Factors: Harvey Ball Analysis

List Of Tables

Table 4.1 Digital Therapeutics: Information on Status of Development and Launch Year
Table 4.2 Digital Therapeutics: Information on Type of Solution
Table 4.3 Digital Therapeutics: Information on Type of Therapy and Purpose of Solution
Table 4.4 Digital Therapeutics: Information on Target Indication(s), Therapeutic Area and Target Population
Table 4.5 Digital Therapeutic Solutions: Information on Prescription Requirement, Duration of Course and Cost of Solution
Table 4.6 Digital Therapeutics: List of Developers
Table 6.1 Digital Therapeutics: List of Companies Profiled
Table 6.2 Akili Interactive: Company Snapshot
Table 6.3 Akili Interactive: Digital Therapeutic Solutions Portfolio
Table 6.4 Akili Interactive: Recent Developments and Future Outlook
Table 6.5 Big Health: Company Snapshot
Table 6.6 Big Health: Digital Therapeutic Solutions Portfolio
Table 6.7 Big Health: Recent Developments and Future Outlook
Table 6.8 dreem: Company Snapshot
Table 6.9 dreem: Digital Therapeutic Solutions Portfolio
Table 6.10 dreem: Recent Developments and Future Outlook
Table 6.11 Kaia Health: Company Snapshot
Table 6.12 Kaia Health: Digital Therapeutic Solutions Portfolio
Table 6.13 Kaia Health: Recent Developments and Future Outlook
Table 6.14 MindMaze: Company Snapshot
Table 6.15 MindMaze: Digital Therapeutic Solutions Portfolio
Table 6.16 MindMaze: Recent Developments and Future Outlook
Table 6.17 Omada Health: Company Snapshot
Table 6.18 Omada Health: Digital Therapeutic Solutions Portfolio
Table 6.19 Omada Health: Recent Developments and Future Outlook
Table 6.20 Pear Therapeutics: Company Snapshot
Table 6.21 Pear Therapeutics: Digital Therapeutic Solutions Portfolio
Table 6.22 Pear Therapeutics: Recent Developments and Future Outlook
Table 6.23 Vida Health: Company Snapshot
Table 6.24 Vida Health: Digital Therapeutic Solutions Portfolio
Table 6.25 Vida Health: Recent Developments and Future Outlook
Table 6.26 Voluntis: Company Snapshot
Table 6.27 Voluntis: Digital Therapeutic Solutions Portfolio
Table 6.28 Voluntis: Recent Developments and Future Outlook
Table 6.29 WellDoc: Company Snapshot
Table 6.30 WellDoc: Digital Therapeutic Solutions Portfolio
Table 6.31 WellDoc: Recent Developments and Future Outlook
Table 6.32 Wellthy Therapeutics: Company Snapshot
Table 6.33 Wellthy Therapeutics: Digital Therapeutic Solutions Portfolio
Table 6.34 Wellthy Therapeutics: Recent Developments and Future Outlook
Table 8.1 Digital Therapeutics: Funding and Investments, Information on Year of Investment, Type of Funding, Amount Invested and Investor(s), 2016 - 2022
Table 8.2 Digital Therapeutics: Funding and Investments, Information on Year of Establishment, Location of Headquarters of Recipients, Type of Therapy and Therapeutic Area
Table 9.1 Digital Therapeutics: List of Collaborations
Table 9.2 Digital Therapeutics: Partnerships and Collaborations, Information on Type of Agreement (Region-wise and Geography-wise)
Table 10.1 Digital Therapeutics: Summary of Marketing Strategies
Table 10.2 Go-to-Market Strategy: Product Specific Websites
Table 11.1 Product Price Evaluation Matrix: Based on Status of Development
Table 11.2 Product Price Evaluation Matrix: Based on Type of Solution
Table 11.3 Product Price Evaluation Matrix: Based on Purpose of Solution
Table 11.4 Product Price Evaluation Matrix: Based on Type of Therapy
Table 11.5 Product Price Evaluation Matrix: Based on Therapeutic Area
Table 11.6 Product Price Evaluation Matrix: Based on Prescription Requirement
Table 11.7 Product Price Evaluation Matrix: Based on Duration of Course
Table 11.8 Product Price Evaluation Matrix: Based on Distribution Channel
Table 15.1 Company Snapshot: Ampersand Health
Table 15.2 Company Snapshot: Canary Health
Table 15.3 Company Snapshot: Dnurse Technology
Table 15.4 Company Snapshot: Embr Labs
Table 15.5 Company Snapshot: Exosystems
Table 15.6 Company Snapshot: Floreo
Table 15.7 Company Snapshot: GAIA
Table 15.8 Company Snapshot: Healios
Table 15.9 Company Snapshot: JOGGO Health
Table 15.10 Company Snapshot: metaMe Health
Table 15.11 Company Snapshot: SelfBack
Table 15.12 Company Snapshot: Somatix
Table 15.13 Company Snapshot: Tilak Healthcare
Table 15.14 Company Snapshot: Turnaround Health
Table 15.15 Company Snapshot: Vida Health
Table 15.16 Company Snapshot: Voluntis
Table 15.17 Company Snapshot: Wellthy Therapeutics
Table 17.1 Digital Therapeutics: Distribution by Status of Development
Table 17.2 Digital Therapeutics: Distribution by Type of Solution
Table 17.3 Digital Therapeutics: Distribution by Type of Therapy
Table 17.4 Digital Therapeutics: Distribution by Purpose of Solution
Table 17.5 Digital Therapeutics: Distribution by Type of Therapy and Purpose of Solution
Table 17.6 Digital Therapeutics: Distribution by Target Indication(s)
Table 17.7 Digital Therapeutics: Distribution by Therapeutic Area
Table 17.8 Digital Therapeutics: Distribution by Target Population
Table 17.9 Digital Therapeutics: Distribution by Prescription Requirement
Table 17.10 Digital Therapeutics: Distribution by Duration of Course
Table 17.11 Digital Therapeutics: Distribution by Cost of Solution (USD)
Table 17.12 Digital Therapeutics Developers: Distribution by Year of Establishment
Table 17.13 Digital Therapeutics Developers: Distribution by Company Size
Table 17.14 Digital Therapeutics Developers: Distribution by Business Model
Table 17.15 Digital Therapeutics Developers: Distribution by Location of Headquarters
Table 17.16 Leading Digital Therapeutics Developers: Distribution by Number of Digital Therapeutics Solutions
Table 17.17 Leading Digital Therapeutics Developers: Distribution by Portfolio Strength, Therapeutic Area and Company Size (4-D Bubble Representation)
Table 17.18 Digital Therapeutics: Distribution by Therapeutic Area and Company Size (Tree Map Representation)
Table 17.19 Digital Therapeutics: Distribution by Regional Activity
Table 17.20 Cardiovascular Disorders: Shift in Trends (2018 - 2023)
Table 17.21 Mental Health Problems: Shift in Trends (2018 - 2023)
Table 17.22 Metabolic Disorders: Shift in Trends (2018 - 2023)
Table 17.23 Neurological Disorders: Shift in Trends (2018 - 2023)
Table 17.24 Substance Use Disorders: Shift in Trends (2018 - 2023)
Table 17.25 Other Therapeutic Areas: Shift in Trends (2018 - 2023)
Table 17.26 Clinical Trial Analysis: Scope and Methodology
Table 17.27 Clinical Trial Analysis: Cumulative Year-wise Trend of Trials by Trial Registration Year, Pre-2017-2022
Table 17.28 Clinical Trial Analysis: Distribution by Trial Status
Table 17.29 Clinical Trial Analysis: Distribution by Trial Registration Year and Trial Status
Table 17.30 Clinical Trial Analysis: Distribution by Trial Phase
Table 17.31 Clinical Trial Analysis: Distribution by Type of Study
Table 17.32 Clinical Trial Analysis: Distribution by Study Design
Table 17.33 Clinical Trial Analysis: Distribution by Study Age
Table 17.34 Clinical Trial Analysis: Distribution by Gender of Patients
Table 17.35 Clinical Trial Analysis: Distribution of Patient Enrolled by Trial Registration Year
Table 17.36 Clinical Trial Analysis: Distribution by Type of Sponsor
Table 17.37 Clinical Trial Analysis: Distribution by Focus Area
Table 17.38 Clinical Trial Analysis: Distribution of Trials by Geography
Table 17.39 Clinical Trial Analysis: Distribution by Trial Registration Year, Recruitment Status and Geography
Table 17.40 Clinical Trial Analysis: Distribution of Patients Enrolled by Geography
Table 17.41 Clinical End-Points Analysis
Table 17.42 Clinical Trials Analysis: Key Clinical End-Points for Metabolic Disorders
Table 17.43 Clinical Trial Analysis: Primary and Secondary Clinical End-Points for Metabolic Disorders
Table 17.44 Funding and Investment Analysis: Distribution of Instances by Year of Establishment and Type of Funding
Table 17.45 Funding and Investment Analysis: Cumulative Year-wise Distribution of Instances, Pre-2019 - 2022
Table 17.46 Funding and Investment Analysis: Cumulative Year-wise Distribution of Amount Invested, Pre-2019 - 2022 (USD Million)
Table 17.47 Funding and Investment Analysis: Distribution of Instances by Type of Funding
Table 17.48 Funding and Investment Analysis: Distribution of Instances by Year and Type of Funding, 2016 - 2022
Table 17.49 Funding and Investment Analysis: Distribution of Amount Invested by Year and Type of Funding, 2016- 2022 (USD Million)
Table 17.50 Funding and Investment Analysis: Summary of Amount Invested, 2016-2022
Table 17.51 Funding and Investment Analysis: Distribution of Instances and Amount Invested by Type of Therapy (USD Million)
Table 17.52 Funding and Investment Analysis: Distribution of Instances by Year and Type of Therapy, 2016 - 2022
Table 17.53 Funding and Investment Analysis: Distribution of Amount Invested by Year and Type of Therapy, Pre-2019 - 2022 (USD Million)
Table 17.54 Funding and Investment Analysis: Distribution of Instances by Therapeutic Area
Table 17.55 Funding and Investment Analysis: Distribution of Amount Invested by Therapeutic Area (USD Million)
Table 17.56 Funding and Investment Analysis: Distribution of Instances by Geography
Table 17.57 Funding and Investment Analysis: Distribution of Amount Invested by Geography (USD Million)
Table 17.58 Most Active Players: Distribution by Number of Instances
Table 17.59 Most Active Players: Distribution by Amount Raised (USD Million)
Table 17.60 Most Active Investors: Distribution by Number of Instances
Table 17.61 Partnerships and Collaborations: Cumulative Year-Wise Trend, Pre-2016-2022
Table 17.62 Partnerships and Collaborations: Distribution by Type of Partnership
Table 17.63 Partnerships and Collaborations: Year-Wise Trend by Type of Partnership, Pre-2016-2022
Table 17.64 Partnerships and Collaborations: Distribution by Type of Partnership and Company Size
Table 17.65 Partnerships and Collaborations: Distribution by Type of Partner
Table 17.66 Partnerships and Collaborations: Year-Wise Trend by Type of Partner, Pre-2016-2022
Table 17.67 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Partner
Table 17.68 Partnerships and Collaborations: Distribution by Type of Partner and Company Size
Table 17.69 Partnerships and Collaborations: Distribution by Type of Therapy
Table 17.70 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Therapy
Table 17.71 Partnerships and Collaborations: Distribution by Type of Partner and Type of Therapy
Table 17.72 Partnerships and Collaborations: Distribution by Therapeutic Area
Table 17.73 Partnerships and Collaborations: Year-Wise Trend by Therapeutic Area
Table 17.74 Partnerships and Collaborations: Distribution by Type of Partner and Therapeutic Area
Table 17.75 Most Active Players: Distribution by Number of Partnerships
Table 17.76 Partnerships and Collaborations: Regional Distribution
Table 17.77 Partnerships and Collaborations: Country-Wise Distribution
Table 17.78 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 17.79 Go-to-Market Strategy: Commonly Used Social Media Platforms
Table 17.80 Go-to-Market Strategy: Online / Print Media Platforms
Table 17.81 Go-to-Market Strategy: Promotional Activities through Official Websites
Table 17.82 Go-to-Market Strategy: Adoption of Different Business Model
Table 17.83 Go-to-Market Strategy: Promotional Activities through Product Websites
Table 17.84 Overall Digital Therapeutics Market, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.85 Digital Therapeutics Market: Distribution by Type of Solution, 2022-2035 (USD Million)
Table 17.86 Digital Therapeutics Market for Standalone Software Applications, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.87 Digital Therapeutics Market for Combination Offerings of Software Application, Device and Personal Coach, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.88 Digital Therapeutics Market for Combination Offerings of Software Application and Personal Coach, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.89 Digital Therapeutics Market for Combination Offerings of Software Application and AI Support, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.90 Digital Therapeutics Market for Combination Offerings of Software Application and Device, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.91 Digital Therapeutics Market for Combination Offerings of Software Application, Device and AI Support, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.92 Digital Therapeutics Market for Other Type of Solutions, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.93 Digital Therapeutics Market: Distribution by Purpose of Solution, 2022-2035 (USD Million)
Table 17.94 Digital Therapeutics Market for Medication Replacement Solutions, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.95 Digital Therapeutics Market for Medication Augmentation Solutions, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.96 Global Digital Therapeutics Market: Distribution by Type of Therapy, 2022 and 2035 (USD Million)
Table 17.97 Digital Therapeutics Market for Curative Therapy, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.98 Digital Therapeutics Market for Preventive Therapy, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.99 Global Digital Therapeutics Market: Distribution by Business Model, 2022-2035 (USD Million)
Table 17.100 Digital Therapeutics Market for B2C Model, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.101 Digital Therapeutics Market for B2B Model, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.102 Global Digital Therapeutics Market: Distribution by Therapeutic Area, 2022-2035 (USD Million)
Table 17.103 Digital Therapeutics Market for Cardiovascular Disorders, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.104 Digital Therapeutics Market for Chronic Pain, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.105 Digital Therapeutics Market for Mental Health Problems, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.106 Digital Therapeutics Market for Metabolic Disorders, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.107 Digital Therapeutics Market for Neurological Disorders, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.108 Digital Therapeutics Market for Respiratory Disorders, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.109 Digital Therapeutics Market for Sleep Disorders, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.110 Digital Therapeutics Market for Substance Use Disorders, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.111 Digital Therapeutics Market for Other Disorders, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.112 Global Digital Therapeutics Market: Distribution by Geography, 2022 and 2035
Table 17.113 Digital Therapeutics Market in North America, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.114 Digital Therapeutics Market in Europe, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.115 Digital Therapeutics Market in Asia, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.116 Digital Therapeutics Market in MENA, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.117 Digital Therapeutics Market in Latin America, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.118 Digital Therapeutics Market in Rest of the World, 2022-2035: Conservative, Base and Optimistic Scenarios (USD Million)
Table 17.119 Women’s Digital Health: Distribution by Type of Solution
Table 17.120 Women’s Digital Health: Distribution by Status of Development
Table 17.121 Women’s Digital Health: Distribution by Product Ratings
Table 17.122 Women’s Digital Health: Distribution by Application Area
Table 17.123 Women’s Digital Health: Distribution by Products Usage with respect to Pregnancy
Table 17.124 Women’s Digital Health: Distribution by Purpose of Solution
Table 17.125 Women’s Digital Health: Distribution by Type of End-Users
Table 17.126 Women’s Digital Health: Distribution by Type of Solution and Application Area
Table 17.127 Women’s Digital Health Developers: Distribution by Year of Establishment
Table 17.128 Women’s Digital Health Developers: Distribution by Company Size
Table 17.129 Women’s Digital Health Developers: Distribution by Location of Headquarters (Region-wise)
Table 17.130 Women’s Digital Health Developers: Distribution by Company Size and Region
Table 17.131 Women’s Digital Health Developers: Distribution by Location of Headquarters (Country-wise)
Table 17.132 Leading Players: Distribution by Number of Solutions
Table 17.133 Regional Landscape: Distribution by Type of Solution

List Of Companies

The following companies and organizations have been mentioned in the report:

1. 2048 Ventures
2. 23andMe
3. 2breathe Technologies
4. 2Morrow
5. 3L Capital
6. 3M Ventures
7. 3VC
8. 4FO Ventures
9. 4point0
10. 500 Startups
11. 5AM Ventures
12. 7wire Ventures
13. 8VC
14. 98point6
15. 9Unicorns
16. A Better Weigh
17. A-Round Capital
18. a thousand colibris  
19. A195 Capital
20. Aavia
21. Ababax Health
22. Abbott
23. AbbVie
24. AbleTo
25. Accel
26. Acceleration Partners
27. Accelmed Partners 
28. Accolade
29. Act Venture Capital
30. Aculys Pharma 
31. Advance Venture Partners
32. Advanced Circulatory Systems
33. Advanced Maternity Innovations
34. Advantage Capital
35. Advantage Consumer Healthcare
36. Aequus Pharmaceuticals
37. Aetna
38. Aflac Corporate Ventures
39. AH Warren Trust
40. AI Fund
41. AIA Group
42. AIB Seed Capital Fund
43. Aindra Systems
44. Airbus
45. Akili Interactive
46. Akilia Partners
47. Al-Ahli Hospital
48. Albion Capital
49. AlbionVC
50. Alex Therapeutics
51. Alfvén & Didriksson
52. Alife Health
53. Alkeon Capital Management
54. Allara Health
55. Allen & Company
56. A.G.P./ Alliance Global Partners
57. Allianz Partners
58. Ally Bridge Group
59. Allysian Sciences
60. Almirall
61. Alpha Femtech
62. Alsace Business Angels
63. AltaIR Capital
64. Althea Group 
65. Altitude Ventures
66. Altoida
67. Alumni Ventures
68. Amadeus Capital Partners
69. Amalgam
70. Amar Seva Sangam
71. Amara Therapeutics
72. Amazon Smbhav Venture Fund
73. Amazon Web Service (AWS)
74. Amboy Street Ventures
75. AME Cloud Ventures
76. Amelia
77. American Association of Diabetes Educators
78. American Diabetes Association
79. Intermountain Healthcare
80. American Investment Holdings
81. American Stroke Association
82. Amgen Ventures
83. Amiko
84. aMoon
85. Ampersand Health
86. Amplify Capital
87. Ananda Impact Ventures.
88. Anastasia Kovba
89. Anchorless Bangladesh
90. Ancora Finance Group
91. Andera Partners
92. Andreessen Horowitz
93. AngelList
94. Anorak Ventures
95. Anthem
96. Anthemis Exponential Ventures
97. Anthemis
98. AOA Dx
99. Aphelion Capital
100. AppBasic
101. Appalachian Regional Healthcare
102. AppliedVR
103. Apricity
104. Apricity Health
105. Aptar
106. Aptar Pharma
107. Arbor Health
108. Arboretum Ventures
109. Ardea Partners
110. ArlanWasHere Investments
111. ArrowMark Partners
112. Artesian
113. Arthritis New Zealand
114. Asabys Partners
115. Asahi Kasei Corporate Ventures Capital
116. Ascensia Diabetes Care
117. Ascension Brighton Center for Recovery
118. Ascension Ventures
119. Aspect Ventures
120. Aspivix
121. Asset Management Ventures
122. Astellas Pharma
123. Astinno
124. AT&T
125. Athena Feminine Technologies
126. Atheneum 
127. Atlantic Labs
128. Atlantic Therapeutics
129. AtlasV Global
130. ATMA Journey Centers
131. Atomico
132. ATX Therapeutics
133. Australasian College of Behavioural Optometrists (ACBO)
134. Autism Impact Fund
135. Autism Learning Partners
136. Autonomous Open Innovation (AOI)
137. Ava Women (Acquired by FemTec)
138. Avaana Capital
139. Avestria Ventures
140. Aviva Ventures
141. Avricore Health
142. Awakn Life Sciences
143. Awesome People Ventures
144. AXA
145. AXA Venture Partners (AVP)
146. Axia Women’s Health
147. B Capital Group
148. Baby2Body
149. Babyscripts
150. Backstage Capital
151. Baillie Gifford
152. balance-app
153. Balderton Capital
154. Banner|Aetna
155. Baseline Ventures
156. Bayer
157. Bayer G4A
158. BBG Ventures
159. BlueCross BlueShield Venture Partners
160. Beats Medical
161. Beaumont Hospital
162. BeCareLink
163. Beehive Holdings
164. BEENEXT 
165. BehaVR
166. Bellabeat
167. Beneufit
168. Bertelsmann India Investments
169. Bessemer Venture Partners
170. Bethnal Green Ventures
171. Better Therapeutics
172. Bettermeant Health
173. Beyond Next Ventures
174. BGF
175. Bia Med
176. Big Health
177. Bill Lucia
178. Bimark
179. Biocon
180. BIOCORP
181. Biofourmis
182. Biogen
183. Biomedix
184. BioTrak Therapeutics
185. Biovotion
186. BIXINK Therapeutics
187. BJC Healthcare
188. Blackbird Ventures
189. Blackstone Growth
190. Blessing Health System
191. bLife
192. Bliss Digital Therapeutics
193. Bloom Burton & Co
194. Bloomer Tech
195. Bloomlife
196. Bloomth
197. Blossom Capital
198. Blue Cross and Blue Shield of Kansas City (Blue KC)
199. Blue Cross Blue Shield of Arizona
200. Blue Cross Blue Shield of Massachusetts
201. Blue Cross Blue Shield of Michigan
202. Blue Cross Blue Shield Venture Partners
203. Blue Mesa Health
204. Blue Note Therapeutics
205. Blue Ox Healthcare Partners
206. Blue Shield of California
207. Blue Water Life Science Fund
208. Blueprint Health
209. BlueRun Ventures
210. BOC Healthcare
211. Boehringer Ingelheim
212. Boehringer Ingelheim Venture Fund
213. Bold Capital Partners
214. Bold Health
215. Bolt Ventures
216. Bonit Capital
217. Bonnier Ventures
218. Bonzun
219. Borski Fund
220. Bose Ventures
221. Boston Medical Center
222. Bpifrance
223. Brain Power
224. Brain+
225. BrainFx
226. Braster
227. Breastlink
228. BreezoMeter
229. Bridge Bank
230. Bridge Builders Collaborative
231. Bridge Health Medical
232. BridgeHealth
233. BrightCap Ventures
234. Brilliantly Warm
235. Bristol-Myers Squibb
236. Brooklands Capital Strategies
237. btov Partners
238. Buoy Health
239. Burst IQ
240. Business Health Care Group
241. B-wom
242. Cabin VC
243. Caffeinated Capital
244. Caixa Capital Risc
245. Calpro AS
246. Cambridge Design Partnership
247. Cambridge Digital Health
248. Cambridge Femtech Society
249. Canaan Partners
250. Canary Health
251. Cancer Institute Hospital of JFCR 
252. Candlelit Therapy
253. Canepa Advanced Healthcare Fund
254. Canopie
255. Canvas Ventures
256. Capier Investments
257. capital300
258. Cara Care
259. Carbomed Medical Solutions
260. CardioRenal
261. Care4Cute
262. CareFirst
263. CareLinx
264. CareSignal
265. CAREvolution
266. Carlyle
267. Carrot & Company
268. Carrot Health (Acquired by Unite Us)
269. Carrum Health
270. CASA SEAT
271. Casdin Capital
272. Castlight Health
273. Catasys
274. Cayaba Care
275. Cedars-Sinai Medical Center
276. Celebrate the Children
277. Centene Corporation
278. Cerner Corporation
279. CerpassRx
280. CES Unveiled
281. CG Ventures
282. Charles River Ventures
283. CheckUp & Choices
284. Chiaroscuro Foundation
285. Chibagin Capital
286. Chiesi 
287. Children’s Community Health Plan
288. Children’s Hospital of Philadelphia
289. Chorus Community Health Plans
290. Chopra Foundation
291. Chorus Health
292. Chugai Pharmaceutical
293. Cigna
294. Cigna Ventures
295. Cipla
296. City Light Capital
297. Civilization Ventures
298. Claritas Health Ventures
299. Clarkson University
300. Clementine app
301. Click Therapeutics
302. CLSA
303. Clue by Biowink
304. CogniFit
305. Cognoa
306. Collaborative Fund
307. Collective Health
308. COLOPL VR Fund
309. Community Health Network of Connecticut.
310. Companion Medical
311. Company K Partners
312. Company Ventures
313. Competitive Health
314. Comprehensive Pain Specialists
315. Concord Health Partners
316. Conference Series
317. Connors Center 
318. Consortium Health Plans
319. CoreHealth Technologies
320. Cority
321. Coroflo
322. Correlation Ventures
323. Cortado Ventures
324. Costco Wholesale
325. Council For Trade and Investment Promotion (CTIP)
326. Cowen Private Investments
327. COYA Partners
328. CRCM Ventures
329. Creandum
330. Creas Impacto
331. Creative Destruction Lab
332. Crescent Ridge Partners
333. Crimsonox Capital
334. Crista Galli Ventures
335. Crohn's & Colitis Foundation
336. Crossroads Treatment Centers
337. Curavit Clinical Research
338. CureApp
339. Curebase
340. Curio Digital Therapeutics
341. Currae Healthtech Fund
342. Toyoshima CVC
343. CVS Health Ventures
344. Cyberdine
345. dacadoo
346. Dai-ichi Life
347. DAK Gesundheit 
348. Dario Health
349. Dartmouth College
350. Dayzz
351. Debiopharm
352. Deerfield Management 
353. Delivering Scientific Innovation for Autism
354. Deloitte
355. Dendera Ventures
356. United States Department of Defense 
357. United States Department of Veteran Affairs
358. Development Bank of Wales
359. Dexcom
360. Dexium Technologies
361. DFJ Growth
362. Danish Diabetes Association
363. Diabnext (Acquired by Glooko)
364. Diasend
365. Digbi Health
366. DG Daiwa Ventures
367. Digital Health Acquisition 
368. Digital Health Today
369. Digithera
370. DigiTx Partners
371. Dignity Health
372. DN Capital
373. Dnurse Technology
374. Doctor on Demand
375. Doha Tech Angels
376. Dopavision
377. Double Peak 
378. Downing Ventures
379. Dragoneer Investment
380. Draper Esprit and Touchstone Innovations
381. DrChrono
382. Dream Incubator
383. Dreamit Ventures
384. Dreem
385. Driehaus Capital Management
386. Droobi Health
387. dTHx
388. Duke University School of Medicine
389. Duopharma Biotech Berhad
390. e&
391. Ease Healthcare
392. Echo Health Ventures
393. eClinicalHealth
394. Eco-Fusion
395. EDBI
396. Eden Strategy Institute
397. Efficient Capacity Fund
398. Ehave
399. EHE Health
400. Ei.Ventures
401. Eisai
402. EIT Health
403. ElaWoman
404. Elda Health
405. Electronics and Telecommunication Research Institute (ETRI)
406. Elevance Health
407. Eli Health
408. Eli Lilly
409. Elidah
410. Ellerca Health
411. EloCare
412. Elvie
413. Elysium Venture Capital
414. Embr Labs
415. Emme
416. Emotional Intelligence Ventures
417. Endeavor Catalyst
418. Endeavour Vision
419. Endodiag
420. Endometrix
421. ENDRA Life Sciences
422. Enovis
423. Enso (Acquired by Hinge Health)
424. Enterprise Ireland
425. Enterprise Ireland Commercialisation Fund
426. Entreé Capital
427. Enzia Ventures
428. EQT Ventures
429. eQventure
430. Ermua City Council
431. Eurazeo
432. European Commission
433. European Innovation Council
434. European Innovation Council and SMEs Executive Agency (EISMEA)
435. Eurostars
436. Evernorth’s Health 
437. Evernow
438. EVERSANA
439. EvidentIQ
440. Evidity Health Capital
441. Exandus
442. Exosystems
443. Expon Capital
444. Express Script
445. Faegre Drinker
446. Fairhaven Health
447. Farallon Capital Management
448. Fearless Ventures
449. Feel Therapeutics
450. Felicis Ventures
451. Femasys
452. FemCy
453. FEMM
454. Femna Health
455. Femometer
456. FemTec Healthcare
457. FemTech Analytics
458. FemTech Focus
459. FemX
460. Fenbushi Capital
461. Ferne
462. Ferrer
463. Fertility Focus
464. FetoLife
465. Fidelity Management and Research Company
466. Fifty Years
467. FinTLV Ventures
468. Finnish Student Health System (FSHS)
469. Fireside Ventures
470. First Nation Group
471. First Round Capital
472. FirstCheck Africa
473. FirstMark Capital
474. Fish & Richardson
475. Fit4D
476. Fitterfly
477. Fizimed
478. Flare Capital Partners
479. Flint Capital
480. Flo Health
481. Flöka
482. Floreo
483. Florida Hospital
484. Flying Health
485. FMZ Ventures
486. Fondation pour l'Innovation Technologique (FIT)
487. Fontys Hogeschool ICT
488. Ford Motor Company
489. Forerunner Ventures
490. Foresight Group
491. Forth Management
492. Fortunis Capital
493. Founder Institute
494. Founders Fund
495. Foundry Group
496. F-Prime Capital
497. Frame Fertility
498. Franklin Templeton
499. Fred Hutchinson Cancer Research Center
500. Freespira
501. Freestyle Capital
502. Frist Center for Autism and Innovation
503. Frontier Venture Capital
504. Frost & Sullivan
505. Frøya Life
506. Fruit Street 
507. Frumtak Ventures
508. Fuel Ventures
509. Future\Perfect Ventures
510. Future Positive Capital
511. FWD Takaful
512. GAIA
513. Gaido Health (Acquired by Biofourmis)
514. Gaingels
515. Gallagher Student Health & Special Risk
516. Gals Bio
517. Games for Health
518. Garmin
519. gBETA Medtech
520. GC VR Tracker Fund
521. Gedeon Richter
522. Gelt Venture Capital
523. General Atlantic
524. General Catalyst
525. General Catalyst 
526. Genesis Ventures
527. Gennev
528. Genoa Telepsychiatry
529. Georgian
530. Giant Leap
531. Gilde Healthcare
532. Ginger
533. GingerBread Capital
534. GlaxoSmithKline
535. Global Brain 
536. Global Founders Capital
537. GlobalYeast
538. Glooko
539. Glow Inc
540. Golden Seeds
541. Google
542. Grand Central Tech
543. Great Heights Family Medicine
544. Green Shield Canada
545. Greycroft
546. GrowX Ventures
547. Grupo Fleury
548. GSK NEXT
549. GSR Ventures
550. GuideWell Mutual Holding Corporation
551. gumi Cryptos Capital (gCC)
552. GV
553. H.I.G. BioHealth Partners
554. Hackster.io
555. Hadean Ventures
556. Halza
557. Hambrecht Ducera Growth Ventures
558. Hannover Re US
559. Happify Health
560. Harvard Business School Association of Northern California (HBSANC)
561. Harvard Medical School
562. Harvard University
563. HAX
564. Haxus
565. Headspace
566. Healios
567. Health & Her
568. Health Allliance Plan
569. Health Catalyst
570. Health Catalyst Capital
571. Health Enterprise Partners (HEP)
572. Health in Her HUE
573. Healthmine
574. Health Transformation Alliance
575. HealthCap
576. Healthcare Innovation Fund
577. Health Inn
578. HealthPartners
579. HealthXL
580. Healthy Trucking Association of America
581. Heartcore Capital
582. Hedia
583. HelloBetter
584. Hello Heart
585. HelloFresh
586. HeraMED
587. Hercules Capital
588. Heritas Capital
589. Heuristic Capital
590. Hevella Capital
591. Highmark Health
592. Highmark Interactive
593. High-Tech Gründerfonds
594. Higi
595. Hikma Ventures
596. Hinduja Group
597. Hinge Health
598. HITLAB
599. Hiventures
600. HLM Venture Partners
601. HMA Capital Partners
602. Holmusk
603. Horizon 2020
604. European Innovation Council (EIC)
605. Hubble Connected
606. Human API
607. Humana
608. Hyde Park Angels
609. Hygieia
610. IBB Ventures
611. IBH Population Health Solutions
612. iBreve
613. Icon Ventures
614. Idinvest Partners
615. Ieso Digital Health
616. iFeel Labs
617. IIB Sant Pau
618. Illinois Department of Healthcare and Family Services
619. Illumigyn
620. Illumina Ventures
621. ImagineMIC™
622. Insan Mulia Abditama 
623. Impact Ventures UK
624. IMPUTE Inc.
625. Incos Invest
626. Indegene
627. India Edison Accelerator
628. India Innovation Initiative
629. Industry Ventures
630. INFOR Financial 
631. Information Technology Academia Collaboration (ITAC)
632. InHealth Ventures
633. Inito
634. inMotion VR
635. inne
636. Innovation Skåne
637. InnovHealth 
638. Inova
639. Insight Partners
640. Insignia Ventures Partners
641. Sant Pau Biomedical Research Institute (IIB Sant Pau)
642. Institute of Mental Health (IMH)
643. Insulet
644. InsurTech.vc
645. Integra Community Care Network
646. Integra Partners
647. Intel Capital
648. Intermountain Ventures
649. International Capital Management
650. International Finance Corporation (IFC)
651. International Medical Center Apps
652. International Technology Law Association (ITechLaw)
653. Invest Detroit
654. Investec Ventures
655. ION Crossover Partners
656. IP Group
657. IPD Capital
658. IPOPEMA Securities
659. Ironwood Pharmaceuticals
660. iSeed Ventures
661. iSono Health
662. Itamar Medical
663. Iterative Capital 
664. IT-Farm
665. ITOCHU
666. ITOCHU Technology Ventures
667. IVP
668. Iwagin Business Creation Capital
669. Iwagin Jigyo Souzou Capital
670. iXensor
671. J.P. Morgan
672. JamJar Investments
673. Janssen Pharmaceutica NV
674. Janssen Research & Development
675. January Ventures
676. JAZZ Venture Partners
677. Jennis
678. Jianke
679. Jichi Medical University
680. JJDC
681. JOGO Health
682. Johns Hopkins HealthCare Solutions
683. Johnson & Johnson
684. Johnson & Johnson Innovation
685. Johnson Venture Partners (JVP)
686. Joint Academy
687. Jolly Good
688. Joy Ventures
689. Joyable
690. Joyance Partners
691. K2 HealthVentures
692. K2 Investment Partners
693. Kaia Health
694. Kakao Ventures
695. Kamet Ventures
696. Kapor Capital
697. Karista
698. Karolinska Institutet
699. Karuna Labs
700. KEGG (Kyoto Encyclopedia of Genes and Genomes)
701. Keio Innovation Initiative
702. Kelvi
703. Kenetic Capital
704. Kentucky Science and Technology Corporation (KSTC)
705. Kheiron Medical Technologies
706. Khosla Ventures
707. Khyria
708. Kicker Ventures
709. Kiio
710. Kima Ventures
711. Kindbody
712. King River Capital
713. King's College London
714. Kinnevik
715. KiOmed Pharma
716. KLAVA Innovation
717. Kleiner Perkins Caufield & Byers
718. Kleiner Perkins Caufield & Byers (KPCB)
719. Koa Health
720. Konna xyz
721. KORE Digital Health Therapeutics
722. Korea Advanced Institute of Science and Technology
723. Korea Technology Finance 
724. Korea Investment Partners
725. Kormeli
726. Kortex Ventures
727. Koshidaka Holdings
728. KTB Network
729. Kurbo Health
730. Kwit
731. Kyma Medical Technologies
732. Kyushu University
733. LabQ International
734. BlackRock Private Equity Partners
735. Lactamo
736. LactApp
737. Lactation Lab
738. Ladera Venture Partners
739. Laguna Investment
740. LAIA
741. Laia 
742. Laidir Foundation
743. Lark Health
744. Launchpad Venture Group
745. Lead Edge Capital
746. League of Innovators
747. Leap Fitness Group
748. Leaps by Bayer
749. Learn Behavioral
750. Learn 
751. Leerink Transformation Partners
752. Leksell Social Ventures
753. Lemonaid Health
754. LetsGetChecked
755. LexisNexis Risk Solutions
756. Lief Therapeutics
757. LifeScan
758. Life Science Innovation Fund (LSI)
759. Lifeforce Capital
760. Lifeline Ventures
761. LifeSense Group (LSG)
762. Lifestyle & Wellness Medical Center
763. Lightspeed Venture Partners
764. Limbix
765. Linchpin Healthcare
766. LionBird Ventures
767. Liquid 2 Ventures
768. Liriro
769. Lisa Health
770. LiveBetter
771. Livia
772. Livongo Health
773. LongHash Ventures
774. Louisiana Department of Health
775. LRVHealth
776. LSP
777. LUCID
778. Lucina Analytics
779. Luma Womb
780. LumiraDx
781. LUNA-endometriose 
782. Lund University
783. Lux Capital
784. M Venture Partners (MVP)
785. M Ventures
786. M12, Microsoft's Venture Fund
787. Mabel
788. Mae
789. Magellan Health
790. Magic Horizons
791. Magnetic Ventures
792. Mahana Therapeutics
793. Mahmee
794. MAIF Avenir
795. Maine Technology Institute
796. Maki.vc
797. Mana Ventures
798. Mangrove Capital Partners
799. Manhattan Venture Partners
800. Manipal Education and Medical Group
801. MannKind 
802. Manulife
803. MAP Health Management
804. MAPFRE
805. Mass General Brigham
806. Massachusetts General Hospital
807. Massachusetts Institute of Technology (MIT)
808. MassChallenge
809. MassMutual Ventures
810. Material Impact
811. Materna Medical
812. Maven Clinic
813. Maven Ventures
814. Maverick Ventures
815. Maveron
816. Maya Digital Health
817. Mayden
818. Mayo Clinic
819. MBS innovation DRIVE
820. McKesson Ventures
821. McKinsey
822. McLean Hospital
823. MDLIVE
824. Medical Mutual of Ohio
825. Medifox Dan
826. MediPeace Vietnam
827. I-Medita
828. MedRhythms
829. MedTech Entrepreneurs
830. Medtech Women
831. Medtronic
832. Medvest Capital
833. MEEZA
834. Meliora Technology
835. Melon Health
836. Mementor (Acquired by ResMed)
837. Memorial Sloan Kettering Cancer Center (MSKCC) 
838. MemorialCare Innovation Fund (MCIF)
839. Menopod
840. Mercer
841. Merchavia
842. Merck
843. Merck Global Health Innovation Fund
844. M Ventures
845. Meridian Street Capital
846. Meritech Capital Partners
847. Mersey Care NHS Foundation Trust
848. Meru Health
849. Meta
850. metaMe
851. MetFlux Research
852. Metrocare Services
853. Metrodora Ventures
854. Metronomic 
855. Microsoft
856. Midlands Engine Investment Fund (MEIF)
857. MiLA Capital
858. MiMARK
859. Min Doktor
860. Mindable Health
861. MindBeacon Group
862. Mind Cure Health
863. Mindmaze
864. Mindset Health
865. MindWise Innovations
866. MINES & Associates
867. Mira
868. Mirae Assets
869. Mitsubishi UFJ Capital
870. I Mercury Capital
871. Mizuho Capital
872. MJog
873. MobileODT
874. Mobio Technologies
875. Modern Fertility
876. Molbio Diagnostics
877. Molten Ventures
878. Monarch Medical Technologies
879. Monashee Investment Management
880. Monkfish Equity
881. Montage Ventures
882. MooDoos Investments
883. Moonai
884. Moonwhale Ventures
885. More Provident Funds
886. Morningside
887. Morningside Group
888. Mountain Group Partners
889. MoveUp
890. MTIP
891. Mundi Ventures
892. Mundipharma
893. MUTU System
894. MyAva
895. My mhealth
896. Myant
897. MyLife ID
898. Nabta Health
899. Nagoya City University
900. Naluri
901. Nantahala Capital Management
902. National Breast Cancer Foundation
903. National Cancer Center (NCC)
904. National Cancer Institute
905. National Cancer Institute (NCI)
906. National Center of Neurology and Psychiatry (NCNP)
907. National Education Association (NEA)
908. National Health Service (NHS)
909. National Healthcare Group (NHG)
910. National Heart Centre Singapore (NHCS)
911. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
912. National Institute of Mental Health
913. National Institute on Aging
914. National Institutes of Health (NIH)
915. National Rheumatoid Arthritis Society
916. National Science Foundation
917. National Science Foundation (NSF)
918. National Technical University of Athens (NTUA)
919. Natural Cycles
920. Navitus Health Solutions
921. Naytal
922. NCL Technology Ventures
923. National Education Association (NEA)
924. Nebrija University
925. Nest Collaborative
926. Neuberger Berman Funds
927. Neuroglee Therapeutics
928. NeuroMetrix
929. Neurotrack
930. New England-Israel Business Council (NEIBC)
931. New Enterprise Associates
932. New Leaf Venture Partners
933. Meritain Health
934. New Mexico Retiree Health Care Authority (NMRHCA)
935. Newsenselab
936. Newtopia
937. Nex Cubed
938. Next AI
939. NEXT Canada
940. NextGen Venture Partners
941. Nexus Venture Partners
942. NGP Capital
943. NHL Alumni Association
944. NightWare
945. National Institute of Health (NIH)
946. Nimble Ventures
947. Nimbus Synergies
948. Nina Capital
949. Niramai
950. Noaber
951. Nokia Growth Partners
952. Noom
953. Nordic Brain Tech
954. Nordic Eye Venture Capital
955. Nori Health
956. Northwell Holdings
957. Norwest Venture Partners
958. Novartis
959. Novartis Venture Fund
960. Novator Partners
961. Novo Holdings
962. Novo Nordisk
963. NSI Ventures
964. Nunaps
965. NursElet
966. Nuvo Group
967. Oak HC/FT
968. Oath Care
969. Ocean Azul Partners
970. OCON Healthcare
971. Octopus Ventures
972. Okhlahoma Health Care Authority
973. Oky
974. Olive Tree Capital
975. Olive Tree Ventures
976. Omada Health
977. Omega Capital Partners
978. Omidyar Technology Ventures
979. Omron Corporation
980. Oncology Care Home Health Specialists
981. One Drop
982. ONE WORLD Training & Investments
983. Ontario Telemedicine
984. Oova
985. Openspace Ventures
986. Operator Partners
987. Optum Ventures
988. Opus Growth
989. Oratel Diagnostics
990. OrbiMed
991. Ordinary Folk
992. Örebro University
993. Orexo
994. Orion
995. Orreco
996. OSF Ventures
997. Ospedale Malcantonese (OSCAM)
998. Otsuka America
999. Otsuka Health Solutions
1000. Otsuka Pharmaceutical 
1001. Oula Health
1002. OurCrowd
1003. Outcomes fund
1004. Ovia Health
1005. Ovira
1006. Ovulai
1007. Ovulation Calculator
1008. Owl Health
1009. Owl Ventures
1010. Oxeon
1011. Oxford Academic Health Science Network
1012. Oxford University
1013. Ozential Digital Therapeutics
1014. PaceZero Capital Partners
1015. Pachamama
1016. Pacific Health Ventures
1017. Pallasite Ventures
1018. Palo Alto Medical Foundation
1019. Parasail Health
1020. Parentlane
1021. Parian Global Management
1022. Partum Health
1023. Pathology Asia
1024. Payor Logic
1025. PayPal
1026. PBJ Capital
1027. Pear Therapeutics
1028. Pegasus Tech Ventures
1029. Pepapp
1030. Peramare
1031. Perceptive Advisors
1032. PeriGen
1033. Pfizer
1034. PFM Health Sciences
1035. Phenomenal Women's Health
1036. Phenomenelle Angels
1037. Philips
1038. Phoenix Insurance
1039. Physera
1040. pi Ventures
1041. Picus Capital
1042. Pilot House
1043. Pixvana
1044. Plackal Tech 
1045. Plan International
1046. Playwing
1047. Plug and Play Tech Centre
1048. Polaris Partners
1049. Polytech Ventures
1050. Pomelo Care
1051. Pond Capital
1052. Pontifax Venture Capital
1053. Portland Seed Fund
1054. PreemieWorld
1055. PregnaScan
1056. Premera Blue Cross
1057. Presence Capital
1058. Primary Health Care Corporation (PHCC)
1059. Prima-Temp
1060. Prime Therapeutics
1061. Prime Venture Partners
1062. Prism Healthcare
1063. Privia Health
1064. Privitar
1065. Proactive for her
1066. Prodeko Ventures
1067. Prognos Health
1068. Progyny
1069. Proov
1070. Propeller Health
1071. Prority Health
1072. Protocol Labs
1073. Prototron
1074. Providence Health & Services
1075. Providence Ventures
1076. Pruksa Group
1077. PsyInnovations
1078. pumpspotting
1079. Punchbowl
1080. Pura Vida Investments
1081. Purdue University
1082. PureTech Health
1083. QBIC - Qatar Business Incubation Center
1084. Qiming Venture Partners
1085. QUAD Investment Management
1086. Quadrille Capital
1087. Qualcomm Life
1088. Quiver Tree Investments
1089. Qure Ventures
1090. Raiing Medical
1091. Rally Health
1092. Raydiant Oximetry
1093. Reaktor Ventures
1094. Red One Medical
1095. RedBrick Health
1096. Redbrick
1097. Redicare Control
1098. Redmile Group
1099. Redox
1100. Reflectance Medical
1101. Region Östergötland
1102. Region Skåne
1103. Renalis
1104. Renovia
1105. Research Society for The Study of Diabetic in India (RSSDI)
1106. ResMed
1107. Resolute Ventures
1108. Restore Health
1109. Rethink Impact
1110. Revelation Partners
1111. Revive Therapeutics
1112. Revon Systems
1113. Rhia Ventures
1114. RHL Ventures
1115. RhythmiaBreath
1116. RISE (Research Institutes of Sweden)
1117. Ro
1118. Roblox
1119. Roche
1120. Roche Diabetes Care
1121. Roche Diagnostics
1122. RoX Health
1123. Royal Society of Medicine 
1124. RRE Ventures
1125. RS Investments
1126. Russell Siegelman
1127. S.R. One
1128. Saama Capital
1129. Safar Partners
1130. Safeguard Scientifics
1131. Sage Capital Partners
1132. Sagentia Innovation
1133. Saisei Ventures
1134. Saison Ventures
1135. Salem Partners
1136. SalesForce
1137. Salumedia
1138. Samsung
1139. Samsung Health
1140. Sandoz
1141. Sano
1142. Sanofi
1143. Sanofi Ventures
1144. Santora Nakama
1145. SAP
1146. Sapiens Ventures
1147. Sapphire Ventures
1148. Sarissa Capital
1149. Sarjan Health
1150. SBI Investment 
1151. Scale Capital
1152. Schoolhouse Partners
1153. Scientific Federation
1154. Scientific Med
1155. SD Venture
1156. Seashore Solutions
1157. Sectoral Asset Management
1158. SEED Capital 
1159. SeedtoB Capital
1160. SelfBack
1161. Sennheiser
1162. Senseonics
1163. Seoul National University Bundang Hospital
1164. Sequoia Capital
1165. Sequoia India
1166. Sera Prognostics
1167. Seraph Venture
1168. Serena Ventures
1169. Seroba Life Sciences
1170. Servier
1171. Sevenlogics
1172. SGInnovate
1173. Shanda Group
1174. Sharecare
1175. Shareholder Value Management
1176. She Loves Tech
1177. Shinsei Bank
1178. Shinsei Corporate Investment
1179. Shionogi
1180. Shire Pharmaceuticals
1181. Sidekick Health
1182. Sidgetop Health
1183. Signant Health
1184. Silicon Valley Bank
1185. Silver Cloud Health
1186. Silver Lake
1187. Simon & Schuster
1188. Simplyhealth
1189. Sivan Innovation
1190. Skånsk Innovationskraft
1191. SMBC Venture Capital
1192. Social Starts
1193. Softbank 
1194. SoftBank Vision Fund
1195. SoftTech
1196. Solera Health
1197. SOMA Breath
1198. SOMPO Digital Lab
1199. Sompo Holdings
1200. Sonormed
1201. Sonova Group
1202. Sony Innovation Fund
1203. SOSV
1204. Sozo Ventures
1205. SparkLabs
1206. Sparrow Ventures
1207. Speak AI
1208. Spice Capital
1209. Spring Mountain Capital
1210. Springboard
1211. Springbuk
1212. SR One
1213. Srirakshaa Healthcare
1214. Stanford Technology Ventures Program
1215. Stanford University
1216. Stanford University Mind & Body Lab
1217. Stanford University School of Medicine
1218. Stanley Park Ventures
1219. Starting Line
1220. Startmate
1221. StartUp Health
1222. Startupbootcamp Digital Health Berlin
1223. StartX Fund
1224. Stateline Angels
1225. StayWell
1226. SteadySense
1227. Steelcase
1228. SteelSky Ventures
1229. SternAegis Ventures
1230. Stewart Greenebaum
1231. Stifel GMP
1232. Storka
1233. Storm Ventures
1234. Stress Point Health
1235. Stripes
1236. Sumitomo Dainippon Pharma
1237. Sumitomo Mitsui Trust Investment
1238. Summer VC
1239. Summit Partners
1240. Summit Reinsurance Services
1241. SureHire
1242. Susmed
1243. SVB Ventures
1244. SVC
1245. Sway Ventures
1246. Swedish Breast Cancer Association
1247. Sweet Capital
1248. Sweetch
1249. Swing Therapeutics
1250. Swiss Healthcare Startups (SHS)
1251. Swiss Re
1252. Symphony Ventures
1253. Syrona Health
1254. Tal Capital
1255. TALi Health
1256. Tamtris Web Services
1257. Target
1258. Target Global
1259. Tech Up For Women
1260. Tech4Eva
1261. Techammer
1262. Techstars
1263. Teijin
1264. Teladoc Health
1265. TELUS Ventures
1266. Tempdrop
1267. Tennessee Department of Intellectual and Developmental Disabilities (DIDD)
1268. Terumo
1269. Texas HALO Fund
1270. The Aplastic Anemia & MDS International Foundation
1271. The Body Literacy Collective
1272. The Female Health Hub
1273. The Harris Center for Mental Health and IDD
1274. The Learning Corp
1275. The Lily Project
1276. The Pelvic Expert
1277. Regents of the University of California
1278. The Research Foundation for The State University of New York 
1279. The Shoko Chukin Bank
1280. The University of Texas Health Science Center at Houston (UTHealth)
1281. The Venture Reality Fund
1282. The Vertical Group
1283. Thimble Point
1284. Think Bigger Capital
1285. Think.Health
1286. Tia
1287. Tiger Global Management
1288. Tilak Healthcare
1289. Titan Capital  
1290. Tokyo Century
1291. Tooly Tech
1292. TOYOSHIMA
1293. Trend Forward Capital
1294. TrialSpark
1295. Trinity Capital
1296. Triumf Health
1297. TruDiary
1298. True Ventures
1299. Trustbridge
1300. TT Capital Partners
1301. Turnaround Health
1302. Tutorify
1303. U.S. Venture Partners
1304. Ubicom Holdings
1305. UCB
1306. UCI Health
1307. Uncork Capital
1308. Union Square Ventures
1309. Unique Nutrition Solutions
1310. United Healthcare
1311. United Nations University International Institute for Global Health (UNU-IIGH)
1312. UnityPoint Health Ventures
1313. Universal Music Group
1314. University Hospitals
1315. University of Applied Sciences and Arts of Southern Switzerland (SUPSI)
1316. University of California
1317. University of Missouri
1318. University of Nebraska Medical Center 
1319. University of New York
1320. University of Pennsylvania
1321. University of Sydney
1322. University of Washington
1323. Unum
1324. UpLift Health
1325. Upright Technologies
1326. Uvi Health
1327. VA Palo Alto Health Care System 
1328. Validic
1329. VCapital 
1330. Vectr Ventures
1331. Vectura
1332. Veera Health 
1333. Velmio
1334. Venrock
1335. Venture Catalysts
1336. Venture Kick
1337. Venture Partners
1338. Vicore Pharma
1339. Victorum Capital Club
1340. Vida Health
1341. Vigo
1342. Virgin Pulse
1343. Virta Health
1344. Virtue Health
1345. Vitadio
1346. Vitality Group
1347. Vivant
1348. Vivid Vision
1349. VNV Global
1350. Voluntis
1351. VSP Vision Care
1352. Wachanga
1353. Wake Forest University
1354. Wakestream Ventures
1355. Walking Ventures
1356. Wallgreens
1357. Wanxiang America Corporation
1358. Watkins-Conti Products
1359. Wavemaker 360
1360. Waypoint Health Innovations
1361. Wayra
1362. WEA Trust
1363. Webb Investment Network
1364. Weill Cornell University
1365. NYP Hospital
1366. Vanderbilt University Medical Center
1367. Welkin Health
1368. WellBe
1369. Welldoc
1370. WellDyne
1371. Wellington Management
1372. Wellington Partners
1373. Wells Fargo
1374. Wellspan Health
1375. Wellthy Therapeutics
1376. Welltoc
1377. Werth Family Investment Associates
1378. Western Development Commission
1379. White Fund
1380. Wildflower Brands
1381. Wildflower Health
1382. Willis Towers Watson
1383. Willow
1384. Wings Fund
1385. Wisconsin Investment Partners
1386. Wisdom LLP
1387. Wise Health System
1388. Withings
1389. Woebot Health
1390. Wolfpack Digital
1391. Women In Bio
1392. Women in Data
1393. WITI (Women in Technology International)
1394. Women of Wearables (WoW)
1395. Women's Health Connecticut  
1396. WomenUP
1397. Wonju Severance Christian Hospital
1398. Woom
1399. Workday Ventures
1400. Workit Health
1401. WP Global Partners
1402. WPS Health Insurance
1403. WRF Capital
1404. Wrnch (Acquired by Hinge Health)
1405. WVU Medicine
1406. Xbird
1407. Xpectives.Health
1408. Y Combinator
1409. Yesmom
1410. Youturn Health
1411. Yozma
1412. Ysios Capital
1413. Zaffre Investments
1414. Zaya Care
1415. Zendesk
1416. ZENworks
1417. Zero Mothers Die
1418. Zillion
1419. Zinc
1420. Zoie Health
1421. Zoll Medical
1422. Zuellig Pharma
1423. Zyus

Source 1: https://dtxalliance.org/understanding-dtx
Source 2: https://www.fda.gov/medical-devices/how-study-and-market-your-device/breakthrough-devices-program